Our results demonstrate how embedding controversial Hostile Environment policies into the NHS compound the multiple barriers already faced by vulnerable migrants when accessing health care.

A daily pill which could be the first to slow Alzheimer’s disease is being considered for use on the NHS. Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient ...